NO314383B1 - Produkt avledet fra melk hovedsakelig fritt for betakasein fra ikke-humanepattedyr, relativ anvendelse og melk - Google Patents
Produkt avledet fra melk hovedsakelig fritt for betakasein fra ikke-humanepattedyr, relativ anvendelse og melk Download PDFInfo
- Publication number
- NO314383B1 NO314383B1 NO19982777A NO982777A NO314383B1 NO 314383 B1 NO314383 B1 NO 314383B1 NO 19982777 A NO19982777 A NO 19982777A NO 982777 A NO982777 A NO 982777A NO 314383 B1 NO314383 B1 NO 314383B1
- Authority
- NO
- Norway
- Prior art keywords
- pro
- milk
- ile
- seq
- gly
- Prior art date
Links
- 102000011632 Caseins Human genes 0.000 title claims abstract description 85
- 108010076119 Caseins Proteins 0.000 title claims abstract description 85
- 235000021247 β-casein Nutrition 0.000 title claims abstract description 50
- 235000013336 milk Nutrition 0.000 title claims abstract description 42
- 239000008267 milk Substances 0.000 title claims abstract description 42
- 210000004080 milk Anatomy 0.000 title claims abstract description 42
- 235000005911 diet Nutrition 0.000 claims abstract description 26
- 230000037213 diet Effects 0.000 claims abstract description 19
- 230000002265 prevention Effects 0.000 claims abstract 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 27
- 235000021240 caseins Nutrition 0.000 claims description 27
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 239000005018 casein Substances 0.000 claims description 15
- 150000001413 amino acids Chemical class 0.000 claims description 14
- 241001465754 Metazoa Species 0.000 claims description 13
- 229940021722 caseins Drugs 0.000 claims description 12
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 12
- 229940127557 pharmaceutical product Drugs 0.000 claims description 12
- 235000018102 proteins Nutrition 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 230000002163 immunogen Effects 0.000 claims description 10
- 101000947120 Homo sapiens Beta-casein Proteins 0.000 claims description 9
- 102000058058 Glucose Transporter Type 2 Human genes 0.000 claims description 8
- 108091006299 SLC2A2 Proteins 0.000 claims description 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 7
- 230000000378 dietary effect Effects 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 102000007079 Peptide Fragments Human genes 0.000 claims 2
- 108010033276 Peptide Fragments Proteins 0.000 claims 2
- 238000010353 genetic engineering Methods 0.000 claims 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 12
- 102000004877 Insulin Human genes 0.000 abstract description 6
- 108090001061 Insulin Proteins 0.000 abstract description 6
- 229940125396 insulin Drugs 0.000 abstract description 6
- 230000001419 dependent effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 24
- 239000004202 carbamide Substances 0.000 description 12
- 239000000872 buffer Substances 0.000 description 11
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000001632 sodium acetate Substances 0.000 description 8
- 235000017281 sodium acetate Nutrition 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000020247 cow milk Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 238000011045 prefiltration Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000021249 α-casein Nutrition 0.000 description 2
- 235000021246 κ-casein Nutrition 0.000 description 2
- BRPMXFSTKXXNHF-IUCAKERBSA-N (2s)-1-[2-[[(2s)-pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H]1NCCC1 BRPMXFSTKXXNHF-IUCAKERBSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283725 Bos Species 0.000 description 1
- 241000283699 Bos indicus Species 0.000 description 1
- 101000741065 Bos taurus Beta-casein Proteins 0.000 description 1
- 102000018711 Facilitative Glucose Transport Proteins Human genes 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108091052347 Glucose transporter family Proteins 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 238000012435 analytical chromatography Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 235000021129 infant diet Nutrition 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108010014614 prolyl-glycyl-proline Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000020254 sheep milk Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/832—Milk; colostrum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feed For Specific Animals (AREA)
- Shafts, Cranks, Connecting Bars, And Related Bearings (AREA)
- Steering Controls (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95RM000850A IT1277964B1 (it) | 1995-12-27 | 1995-12-27 | Prodotto derivato da latte, sostanzialmente esente da betacaseina di mammifero non umano e relativo uso |
| PCT/EP1996/005846 WO1997024371A1 (en) | 1995-12-27 | 1996-12-27 | Product derived from milk substantially free of beta casein from non-human mammals and relative use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO982777L NO982777L (no) | 1998-06-16 |
| NO982777D0 NO982777D0 (no) | 1998-06-16 |
| NO314383B1 true NO314383B1 (no) | 2003-03-17 |
Family
ID=11403735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19982777A NO314383B1 (no) | 1995-12-27 | 1998-06-16 | Produkt avledet fra melk hovedsakelig fritt for betakasein fra ikke-humanepattedyr, relativ anvendelse og melk |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6750203B1 (pt) |
| EP (1) | EP0871662B1 (pt) |
| AT (1) | ATE207079T1 (pt) |
| AU (1) | AU720411B2 (pt) |
| BR (1) | BR9612346A (pt) |
| CA (1) | CA2241171C (pt) |
| DE (1) | DE69616088T2 (pt) |
| ES (1) | ES2164938T3 (pt) |
| IT (1) | IT1277964B1 (pt) |
| NO (1) | NO314383B1 (pt) |
| NZ (1) | NZ325826A (pt) |
| WO (1) | WO1997024371A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7094949B2 (en) * | 1995-05-16 | 2006-08-22 | A2 Corporation Limited | Breeding and milking cows for milk free of β-casein A1 |
| GB9912852D0 (en) * | 1999-06-02 | 1999-08-04 | Regen Therapeutics Plc | Peptides |
| GB0029777D0 (en) * | 2000-12-06 | 2001-01-17 | Regen Therapeutics Plc | Peptides |
| EP1568707A1 (en) * | 2004-02-26 | 2005-08-31 | Puleva Biotech, S.A. | Antihypertensive peptides from casein hydrolysates |
| EP2270133B1 (en) * | 2008-04-22 | 2015-06-24 | Corporación Alimentaria Peñasanta (Capsa) | Method for obtaining a novel strain of bifidobacterium bifidum with activity against infection by helicobacter pylori |
| WO2010119088A2 (en) * | 2009-04-15 | 2010-10-21 | Bodo Melnik | Milk and milk-based products modified to exhibit a reduced insulinemic index and/or reduced mitogenic activity |
| US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
| US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
| US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
| US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
| JP2022531390A (ja) * | 2019-05-02 | 2022-07-06 | ニュー カルチャー インコーポレイテッド | チーズおよびヨーグルト様組成物ならびに関連する方法 |
| US11771105B2 (en) | 2021-08-17 | 2023-10-03 | New Culture Inc. | Dairy-like compositions and related methods |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4501585A (en) * | 1982-08-23 | 1985-02-26 | Friedman Laura L | Mother's milk harvesting and collection device |
| EP0832981A1 (en) * | 1987-02-17 | 1998-04-01 | Pharming B.V. | DNA sequences to target proteins to the mammary gland for efficient secretion |
| JP2623342B2 (ja) * | 1989-06-01 | 1997-06-25 | 雪印乳業株式会社 | 脱塩乳類の製造方法 |
| FR2650955B1 (fr) * | 1989-08-16 | 1992-01-10 | Agronomique Inst Nat Rech | Procede d'obtention, a partir de la caseine beta, de fractions enrichies en peptides a activite biologique et les fractions peptidiques obtenues |
| US5795611A (en) * | 1989-12-20 | 1998-08-18 | Slattery; Charles W. | Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein |
| FR2663637B1 (fr) * | 1990-06-25 | 1992-09-18 | Eurial | Procede et dispositif pour l'obtention de caseine beta. |
| WO1993004171A1 (en) | 1991-08-19 | 1993-03-04 | Symbicom Aktiebolag | Human beta-casein, process for producing it and use thereof |
| WO1994006306A1 (en) * | 1992-09-22 | 1994-03-31 | New Zealand Dairy Board | A process for producing beta-casein enriched products |
| FR2714390B1 (fr) * | 1993-12-23 | 1996-03-08 | Agronomique Inst Nat Rech | Procédé d'obtention de produits peptidiques et produits obtenus. |
| US5643880A (en) * | 1994-05-26 | 1997-07-01 | Abbott Laboratories | Product for inhibition of attachment of H. influenzae to human cells |
| DE69536000D1 (de) * | 1994-11-04 | 2009-10-22 | A2 Corp Ltd | Selektionsverfahren für nicht-diabetogene milch oder milchprodukte sowie hierdurch erfasste milch oder milchprodukte |
| ATE297125T1 (de) * | 1995-05-16 | 2005-06-15 | A2 Corp Ltd | Nahrungsmittel und herstellungsverfahren |
-
1995
- 1995-12-27 IT IT95RM000850A patent/IT1277964B1/it active IP Right Grant
-
1996
- 1996-12-27 AT AT96944662T patent/ATE207079T1/de active
- 1996-12-27 AU AU13066/97A patent/AU720411B2/en not_active Expired
- 1996-12-27 US US09/095,639 patent/US6750203B1/en not_active Expired - Lifetime
- 1996-12-27 EP EP96944662A patent/EP0871662B1/en not_active Expired - Lifetime
- 1996-12-27 CA CA002241171A patent/CA2241171C/en not_active Expired - Lifetime
- 1996-12-27 NZ NZ325826A patent/NZ325826A/xx not_active IP Right Cessation
- 1996-12-27 BR BR9612346-0A patent/BR9612346A/pt not_active Application Discontinuation
- 1996-12-27 ES ES96944662T patent/ES2164938T3/es not_active Expired - Lifetime
- 1996-12-27 WO PCT/EP1996/005846 patent/WO1997024371A1/en active IP Right Grant
- 1996-12-27 DE DE69616088T patent/DE69616088T2/de not_active Expired - Lifetime
-
1998
- 1998-06-16 NO NO19982777A patent/NO314383B1/no not_active IP Right Cessation
-
2004
- 2004-03-04 US US10/793,111 patent/US7091320B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997024371A1 (en) | 1997-07-10 |
| DE69616088D1 (de) | 2001-11-22 |
| BR9612346A (pt) | 1999-12-28 |
| NO982777L (no) | 1998-06-16 |
| CA2241171C (en) | 2007-11-13 |
| EP0871662A1 (en) | 1998-10-21 |
| ITRM950850A0 (pt) | 1995-12-27 |
| NZ325826A (en) | 2000-05-26 |
| US7091320B2 (en) | 2006-08-15 |
| EP0871662B1 (en) | 2001-10-17 |
| ES2164938T3 (es) | 2002-03-01 |
| AU1306697A (en) | 1997-07-28 |
| NO982777D0 (no) | 1998-06-16 |
| AU720411B2 (en) | 2000-06-01 |
| US6750203B1 (en) | 2004-06-15 |
| IT1277964B1 (it) | 1997-11-12 |
| DE69616088T2 (de) | 2002-08-01 |
| CA2241171A1 (en) | 1997-07-10 |
| ATE207079T1 (de) | 2001-11-15 |
| US20050176638A1 (en) | 2005-08-11 |
| ITRM950850A1 (it) | 1997-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR940003938B1 (ko) | 펩타이드 제제의 제조방법 | |
| TWI251468B (en) | A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance | |
| Schlimme et al. | Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects | |
| Antila et al. | Opioid peptides derived from in-vitro proteolysis of bovine whey proteins | |
| De Meulenaer et al. | Isolation and purification of chicken egg yolk immunoglobulins: a review | |
| CN101594785B (zh) | 潜在免疫原性降低的乳蛋白水解产物 | |
| Morgan et al. | Glycation of bovine β‐Lactoglobulin: effect on the protein structure | |
| NO314383B1 (no) | Produkt avledet fra melk hovedsakelig fritt for betakasein fra ikke-humanepattedyr, relativ anvendelse og melk | |
| AU2014324897A1 (en) | Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof | |
| EP0671126B1 (en) | Low-phosphorus whey protein, process for producing the same, hydrolyzate of purified low-phosphorus whey protein, and process for producing the same | |
| JP2003520771A (ja) | ペプチド | |
| NO325836B1 (no) | Peptid som inhiberer forhoyede triglyseridnivaer i blod, samt anvendelse derav | |
| Huang et al. | Investigation of the allergenicity of β-lactoglobulin and its cleavage fragments | |
| DK0871366T3 (da) | Födevareprodukt og fremgangsmåde til fremstilling heraf | |
| EP3430390B1 (en) | Molecular origin of allergy | |
| EP0487619B1 (fr) | Procede d'obtention, a partir de la caseine beta, de fractions enrichies en peptides a activite biologique et les fractions peptidiques obtenues | |
| JP2024513302A (ja) | アレルゲン性が減少した免疫原性タンパク質加水分解物 | |
| JP2000503531A (ja) | 非ヒト哺乳動物由来のベータカゼインを実質的に含まない乳から誘導された生産物及び関連する使用 | |
| US20040162244A1 (en) | Novel peptides use as angiotensin converting enzyme inhibitor and preparation process thereof | |
| JP3657067B2 (ja) | 低タンパク・低アレルゲン米の製造方法並びに加工食品の製造方法 | |
| JPH067092A (ja) | 新規タンパク食品素材 | |
| JP2003325131A (ja) | アレルゲン低減天然エキスの製造法 | |
| Lee et al. | frorn the Root of Panar ginslsw | |
| Tokita | Immunochemical properties and infant allergenicities of milk | |
| NO873481L (no) | Peptidpreparat, fremgangsmaate for fremstilling derav og anvendelse av peptidpreparatet. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |